Article Listing - Sanofi-Aventis wins Lovenox patent appeal
THE NEW EC REGULATORY ENVIRONMENT
20 April 1992
The main problem with the current procedures for registering pharmaceutical products within the member states of the European Community has...
ALBANIAN PHARMA ASSOCIATION
20 April 1992
Albania's Ministry of Health has approved the establishment of the Albanian Pharmaceutical Assoc-iation, reports the ATA news agency. The new...
BULLETIN REViEWS EPOETIN
20 April 1992
Addressing the role of recombinant erythropoietin as a treatment for anemic patients with renal failure and other potentially responsive conditions,...
IMMUNIZATION FORM CONFUSION IN USA
20 April 1992
A series of immunization information forms may be a source of confusion for many Americans seeking vaccinations for their children,...
US BIOSCIENCE STOCK SALE CANCELLED
20 April 1992
Marion Merrell Dow, the US pharmaceutical company, has withdrawn its request for registration and sale of all the common stock...
PATENT EXTENSION SOUGHT BY UPJOHN
20 April 1992
US pharmaceutical firm Upjohn, which is seeking an extension of the patent term of its non-steroidal anti-inflammatory drug Ansaid (flurbiprofen),...
POSSIBLE ARTHRITIS TREATMENT DISCOVERED
20 April 1992
Biochemists at the University of Toronto, Canada, have discovered an antioxidant compound, purpurogallin, which they say could prevent cell damage...
FURTHER CONTROVERSY SURROUNDS TAMOXIFEN
20 April 1992
ICI's breast cancer drug tamoxifen has been linked with five deaths from liver disease in the UK. But the Committee...
APPOINTMENTS AT UK HEALTH MINISTRY
20 April 1992
Following the Conservative victory at the UK General Election, Virginia Bottomley has moved up from Health Minister to become...
SIR ARNOLD BURGEN RETIRES
20 April 1992
Sir Arnold Burgen has retired as a non-executive director of Amersham International, UK.
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
